Publications by authors named "Johannes H J Klaver"
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
Freekje van Asten Kim U Evers-Birkenkamp Janneke J C van Lith-Verhoeven Yvonne de Jong-Hesse Vincent P T Hoppenreijs Johannes H J Klaver
Acta Ophthalmol
March 2015
Purpose: The HELIOS (Health Economics with Lucentis in Observational Settings) study was designed on request of the Dutch Health Authority for an observational study to assess the effectiveness and safety of ranibizumab for neovascular age-related macular degeneration (wet AMD) in daily practice.
Methods: The HELIOS study was a 2-year prospective, observational, open-label, multicentre study involving 14 sites. Patients with wet AMD were enrolled and observed for a period of 24 months.